Drug Name: | Keppra |
---|
Drug Class: | Antiepileptic drug |
---|
Mechanism of Action: | Binds to synaptic vesicle protein SV2A, which is thought to modulate neurotransmitter release |
---|
Use: | - Treatment of partial-onset seizures
- Adjunctive therapy for myoclonic seizures in patients with juvenile myoclonic epilepsy
- Adjunctive therapy for primary generalized tonic-clonic seizures
|
---|
Side Effects: | - Dizziness
- Somnolence
- Headache
- Asthenia
- Infection
- Nausea
- Vomiting
- Anorexia
|
---|
Contraindications: | - Hypersensitivity to levetiracetam
- Renal impairment
|
---|
Specialty: | - Neurology
- Emergency Medicine
- Critical Care
|
---|